Attenuated sympathoadrenal responses, but not severe hypoglycemia, during aggressive glycemic therapy of early type 2 diabetes

Diabetes

Volumn 58, Issue 3, 2009, Pages 515-517

  Amiel, Stephanie A ^a   Cryer, Philip E ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIDIABETIC AGENT; C PEPTIDE; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLYCOSYLATED HEMOGLOBIN;

ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; DIABETIC PATIENT; DISEASE DURATION; DISEASE SEVERITY; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN RELEASE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL; ADRENAL GLAND; BLOOD; BLOOD GLUCOSE MONITORING; HOMEOSTASIS; INNERVATION; METABOLISM; PATHOPHYSIOLOGY; SKELETAL MUSCLE;

ADRENAL GLANDS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; EPINEPHRINE; GLUCAGON; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MUSCLE, SKELETAL; SYMPATHETIC NERVOUS SYSTEM;

EID: 62749162621     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-1647     Document Type: Note

References (26)

1. Cryer PE: The barrier of hypoglycemia in diabetes. Diabetes 57:3169-3167, 2008
2. Cryer PE: Hypoglycemia in Diabetes: Pathophysiology Prevalence and Prevention. Alexandria, VA, American Diabetes Association, 2009
3. Zammitt NN, Frier BM: Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 28:2948-2961, 2005
4. Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R, Band MM, Reekie G, Leese GP, The DARTS/MEMO Collaboration: Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med 22:749-755, 2005
5. Mühlhauser I, Overmann H, Bender R, Bott U, Berger M: Risk factors for severe hypoglycaemia in adult patients with type 1 diabetes: a prospective population-based study. Diabetologia 41:1274-1282, 1998
6. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
7. Leese GP, Wang J, Broomhall J, Kelly P, Marsden A, Morrison W, Frier BM, Morris AD, DARTS/MEMO Collaboration: Frequency of severe hypoglyce- mia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 26:1176-1180, 2003
8. U.K. Hypoglycaemia Study Group: Risk of hypoglycaemia in type 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 50:1140-1147, 2007
9. Amiel SA, Dixon TD, Mann R, Jameson K: Hypoglycaemia in type 2 diabetes. Diabet Med 25:245-254, 2008
10. Towler DA, Havlin CE, Craft S, Cryer PE: Mechanism of awareness of hypoglycemia: perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 42:1791-1798, 1993
11. DeRosa MA, Cryer PE: Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation. Am J Physiol Endocrinol Metab 287: E32-E41, 2004
12. Dagogo-Jack SE, Craft S, Cryer PE: Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. J Clin Invest 91:819-828, 1993
13. Segel SA, Paramore DS, Cryer PE: Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 51:724-733, 2002
14. Ryder RE, Owens DR, Hayes TM, Ghatei MA, Bloom SR: Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy. BMJ 301:783-787, 1990
15. Heller S, Cryer PE: Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondia-betic humans. Diabetes 40:223-226, 1991
16. Davis SN, Shavers C, Mosqueda-Garcia R, Costa F: Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes 46:1328-1335, 1997
17. Davis SN, Mann S, Briscoe VJ, Ertl AC, Tate DB: Effects of intensive therapy and antecedent hypoglycemia on counterregulatory responses to hypoglycemia in type 2 diabetes. Diabetes 58:701-709, 2009
18. Gjessing HJ, Matzen LE, Faber OK, Frølund A: Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes. Diabetologia 32:305-311, 1989
19. Service FJ, Rizza RA, Zimmerman BR, Dyck PJ, O'Brien PC, Melton LJ III: The classification of diabetes by clinical and C-peptide criteria: a prospective population-based study. Diabetes Care 20:198-201, 1997
20. Spyer G, Hattersely AT, Macdonald IA, Amiel SA, MacLeod KM: Hypogly-caemic counterregulation at "normal" blood glucose concentrations in patients with well-controlled type 2 diabetes. Lancet 356:1970-1974, 2000
21. Korzon-Burakowska A, Hopkins D, Matyka K, Lomas J, Pernet A, Mac- donald IA, Amiel SA: Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes. Diabetes Care 21:282-290, 1998
22. Adler GK, Bonyhay I, Failing H, Waring E, Dotson S, Freeman R: Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control. Diabetes 58:360-366, 2009
23. Robinson RT, Harris ND, Ireland RH, Macdonald IA, Heller SR: Changes in cardiac repolarization during clinical episodes of nocturnal hypoglycaemia in adults with type 1 diabetes. Diabetologia 47:312-315, 2004
24. Dluhy RG, McMahon GT: Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med 358:2630-2633, 2008
25. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2653, 2005
26. Holman RR, Paul SK, Ethel MA, Matthews DR, Neil HAW: 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:15771589, 2008